Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2006
11/07/2006US7132265 Circular site-directed mutagenesis
11/07/2006US7132261 Nuclear localization peptides for estrogens; antitumor agents; anticarcinogenic agents; hormone replacement therapy; bradycardial agents
11/07/2006US7132256 cell-based assay for screening for inhibitors of mPGES (microsomal prostaglandin E2 synthase); mPGES inhibitors are potential therapeutic approaches for inflammation and pain
11/07/2006US7132255 drug screening for compounds that enhance or suppress killer T cell activity by contacting a population of killer T cells which express biliary glycoprotein with a compound that binds biliary glycoprotein and determining the cytotoxicity or proliferation of the killer T cells relative to a control
11/07/2006US7132254 detecting phycocyanins and cyanobacteria in water such as freshwater lakes; toxic bloom detection; involves measurement, calculation and transmission of data
11/07/2006US7132253 lowered activity for N-ethylglycine; reagent for measuring creatinine or creatine
11/07/2006US7132252 Comprises fluorophores selected from 7-hydroxycoumarin derivtives, resorufin, and a fluorescein; drug screening
11/07/2006US7132251 Method and composition for analyzing a carbohydrate polymer
11/07/2006US7132250 Isopentenyl diphosphate biosynthetic enzymes
11/07/2006US7132249 Method of determining allergenic food on surfaces
11/07/2006US7132248 Uses of galanin GALR2 receptors
11/07/2006US7132243 Propagation lymphocytes; obtain cells, incubate in nutrient broth, propagate recover cells
11/07/2006US7132242 Method and device for targeted delivery of materials to selected single cells
11/07/2006US7132241 Using fluorescence activated cell sorting to identify and separate cell expressing nucleotide sequence coding transcribing interleukin-4
11/07/2006US7132240 Obtaining chromosomal DNA from plants for preparing expression vectors comprising artificial chromosomes
11/07/2006US7132239 Determination of a genotype of an amplification product at multiple allelic sites
11/07/2006US7132238 Method of determining a chemotherapeutic regimen based on ERCC1 expression
11/07/2006US7132237 Avian leukosis viruses and polypeptide display
11/07/2006US7132236 Composition and method for optimized hybridization using modified solutions
11/07/2006US7132235 Reagent kit for determining specific nucleotide variations
11/07/2006US7132234 or drug targets; contacting a poxviral p28 polypeptide with a candidate agent, and determining an effect on ubiquitin ligase activity of the p28; ubiquitylating a substrate by combining an E1 polypeptide, an E2 polypeptide, ubiquitin and a poxvirus P28 protein; variola virus (smallpox) drug discovery
11/07/2006US7132233 using capture oligonucleotides, primers and probes derived from conserved regions of the West Nile virus genome
11/07/2006US7132232 Diagnosing mammary gland cancer; obtain mammary gland fluid, detect preferential virus in fluid, evaluate for cancer
11/07/2006US7132231 Fluorescence polarization method for determining viral inhibitors
11/07/2006US7132230 Evaluation of toxicity of a specimen used in the diagnosis of viral infection disease of sturgeon; useful in diagnosis of fish viral infections
11/07/2006US7132122 Direct micro-patterning of lipid bilayers using UV light and selected uses thereof
11/07/2006US7132121 Inhibition of viral infection using antigen-binding proteins
11/07/2006US7132101 Compositions and methods for eliciting an immune response to gram-negative bacterial infections
11/07/2006US7132041 Methods of determining the concentration of an analyte in a fluid test sample
11/07/2006CA2039517C Dna probe signal amplification
11/02/2006WO2006116761A2 Expandable support device and methods of use
11/02/2006WO2006116756A1 Multiple-rnai expression cassettes for simultaneous delivery of rnai agents related to heterozygotic expression patterns
11/02/2006WO2006116726A2 Multi-color light detection with imaging detectors
11/02/2006WO2006116708A2 Method of minimizing reagent consumption in microplate-based reactions
11/02/2006WO2006116699A2 Method and system for absolute platelet percent aggregation determination
11/02/2006WO2006116684A2 Methods of predicting methotrexate efficacy and toxicity
11/02/2006WO2006116602A2 Markers associated with the therapeutic efficacy of glatiramer acetate
11/02/2006WO2006116407A2 Compositions and methods for spinocerebellar ataxia
11/02/2006WO2006116360A2 Evaluating bacterial lethality of containerized food production
11/02/2006WO2006116321A2 Bead-based flow cytometry detection methods
11/02/2006WO2006116303A2 Fluorescent multiplex hpv pcr assays
11/02/2006WO2006116276A2 Real-time hpv pcr assays
11/02/2006WO2006116272A1 Compositions and methods for binding agglomeration proteins
11/02/2006WO2006116197A2 Methods of identifying individuals at risk of perioperative myocardial injury, major adverse cardiac events, cognitive decline, arrhythmias, depression or bleeding
11/02/2006WO2006116127A2 Compositions for use in identification of bacteria
11/02/2006WO2006116018A2 Medical test probe for cell sample collection
11/02/2006WO2006116016A2 Molecular determinants of egfr kinase inhibitor response in glioblastoma
11/02/2006WO2006115870A2 Multiplex microparticle system
11/02/2006WO2006115570A2 Small nucleic acid detection probes and uses thereof
11/02/2006WO2006115548A2 Subunit vaccine against west nile viral infection
11/02/2006WO2006115426A1 Method for controlling biological processes and a device for carrying out said method
11/02/2006WO2006115297A1 Method for evaluating compound using barlp and substance for suppressing eating and body weight
11/02/2006WO2006115295A1 Compositions and methods for treating hemostasis disorders associated with clec-2 signal transduction
11/02/2006WO2006115234A1 Detection method for allergy-causing substance and screening method for allergy inhibitor
11/02/2006WO2006115181A1 Method of modifying plant characters
11/02/2006WO2006115047A1 Gene whose expression changes in conjunction with diabetic conditions and utilization thereof
11/02/2006WO2006115026A1 Humanin receptor or humanin-like polypeptide receptor
11/02/2006WO2006114995A1 Method of detecting hybridization by using intercalator
11/02/2006WO2006114647A1 Ion chann
11/02/2006WO2006114245A2 Identification of human gene sequences of cancer antigens expressed in metastatic carcinoma and involved in metastasis formation, and their use in cancer diagnosis, prognosis and therapy
11/02/2006WO2006113979A1 Method for identifying guignardia citricarpa
11/02/2006WO2006094748A3 Method for evaluating the vitality of chlorophyll-containing biological samples
11/02/2006WO2006090288A3 Human autism susceptibility genes encoding a neurotransmitter transporter and uses thereof
11/02/2006WO2006090212A3 Method of growing bacteria to deliver bioactive compounds to the intestine of ruminants
11/02/2006WO2006088876A3 Method of forming a biological sensor
11/02/2006WO2006087634A3 Uses of human autism susceptibility gene encoding a kinase
11/02/2006WO2006086573A3 Diagnostic assay for orientia tsutsugamushi by detection of responsive gene expression
11/02/2006WO2006067254A3 Method and device for the in vitro diagnosis of familial hypercholesterolemia, based on the detection of mutations in the gene sequence of the low-density lipoprotein receptor (ldlr)
11/02/2006WO2006062882A3 Protein-protein interaction detection system using fluorescent protein microdomains
11/02/2006WO2006043100A3 Methods for genotyping hcv
11/02/2006WO2006039663A3 Methods for the administration of iloperidone
11/02/2006WO2006036737A3 Methods for identifying new drug leads and new therapeutic uses for known drugs
11/02/2006WO2006034348A3 Enhanced antisense oligonucleotides
11/02/2006WO2006031930A3 Modulation of xbp-1 activity for treatment of metabolic disorders
11/02/2006WO2006030325A3 Method for identifying antimicrobial molecules which interfere with apoliporotein n-acyltransferase activity
11/02/2006WO2006028867A3 Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling
11/02/2006WO2006027099B1 Enzyme conjugates with a programmable specificity, which react in a highly specific manner with dna
11/02/2006WO2006012351B1 Markers for brain damage
11/02/2006WO2005110493A8 Methods for delivering mbd peptide-linked agent into cells under conditions of cellular stress
11/02/2006WO2005100590B1 Cell display libraries
11/02/2006WO2005095638B1 A kit for measuring the thrombin generation in a sample of a patient’s blood or plasma
11/02/2006WO2005072262A3 Methods and compositions for evolving microbial hydrogen production
11/02/2006WO2005052543A3 Affinity domain for analyte sensor
11/02/2006WO2002044994A3 Systems and methods for detection assay ordering, design, production, inventory, sales and analysis for use with or in a production facility
11/02/2006US20060248617 Method of targeted gene disruption, genome of hyperthermostable bacterium and genome chip using the same
11/02/2006US20060248611 Altered fad2 and fad3 genes in brassica and the molecular marker-assisted detection thereof
11/02/2006US20060248605 Beta-amyloid peptide-binding proteins and polynucleotides encoding the same
11/02/2006US20060248604 Adeno-associated virus-delivered ribozyme compositions and methods of use
11/02/2006US20060248602 Contacting polynucleotide with acetylthiourea, N,N-dimethylthioformamide, N,N'-diphenylthiourea, N-ethylthiourea, 2-imidazolidinethione, 4(6)-methyl-2-thiouracil, N-methylthiourea, phenylthio-carbamid, 6-phenyl-2-thiouracil, 6-propyl-2-thiouracil, tetramethylthiourea, thioacetamide, thioacetanilide
11/02/2006US20060248601 Modification of organelle metabolism by unc-51-like kinases roma1 or 2tm proteins
11/02/2006US20060247420 Immune cell recptor ligand and immune cell receptor
11/02/2006US20060247202 Expression vector for use as regulatory tool in genetic engineering; useful for reducing the expression of endogenous mRNA and any substantially similar endogenous mRNA
11/02/2006US20060247199 Methods and products for manipulating uncoupling protein expression
11/02/2006US20060247198 TGF-beta type receptor cDNAs encoded products and uses therefor
11/02/2006US20060247196 Yeast genes that affect viral replication
11/02/2006US20060247192 Control of apoptosis
11/02/2006US20060247190 Compositions and methods for treating human papillomavirus mediated disease
11/02/2006US20060246589 Disintegrin and metalloproteinase containing thrombospondin 1-like domains (ADAMTS); ADAMTS13 protease and to nucleic acids encoding ADAMTS13 proteases; von Willebrand bactor cleaving protease activity; treating acquired thrombotic thrombocytopenic purpura; anticoagulant drug development
11/02/2006US20060246586 Chromosome-based platforms
11/02/2006US20060246569 Packaging systems for human recombinant adenovirus to be used in gene therapy